申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP0900791A1
公开(公告)日:1999-03-10
A tetrazole derivatives of formula (I)
wherein R1 is H, alkyl, alkoxy, carbocyclic ring, hetero ring, alkyl or alkoxy substituted by carbocyclic ring or hetero ring, etc.; AA1 is bond or
AA2 is bond or
AA1 and AA2, together, may have the formula (a);
Y is the formula (b)
(in which Tet ring is tetrazole; Z is alkylene, alkenylene, O, S, SO, SO2, NR26, methylene in alkylene replaced by O, S, -SO-, SO2- or -NR26-; E is H, alkyl, COOR27or
in which Cyc is carbocyclic ring or hetero ring);
a non-toxic salt thereof, an acid addition salt thereof or a hydrate thereof which has a pharmaceutical agents as an active ingredient. The compound of the formula (I) has an inhibitory effect on interleukin-1β converting enzyme, therefore, they are useful for prevention and/or treatment of various kinds of inflammatory disease.
式 (I) 的
四唑衍
生物
其中 R1 是 H、烷基、烷
氧基、
碳环、杂环、被
碳环或杂环取代的烷基或烷
氧基等;
AA1 是键或
AA2 是键或
AA1 和
AA2 合在一起可具有式(a);
Y 是式 (b)
(其中 Tet 环为
四氮唑;Z 为亚烷基、
烯基、O、S、SO、SO2、NR26、亚烷基中被 O、S、-SO-、SO2- 或-NR26- 取代的亚
甲基;E 为 H、烷基、COOR27 或
其中 Cyc 为
碳环或杂环);
以药物制剂为活性成分的无毒盐、酸加成盐或
水合物。式(I)化合物对白细胞介素-1β转换酶具有抑制作用,因此可用于预防和/或治疗各种炎症性疾病。